However, the knockdown of ADAR2 reversed the suppressive effect exerted by SNORD113-3 on the expression of PKM2 and ACLY, resulting in the augmentation of glycolipid metabolism and the enhancement of GBM cell proliferation (Supplementary Figs. 3I and S3A–H). Here, ACLY is linked to glioblastoma.